Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Green Tea Catechin Is an Alternative Immune Checkpoint Inhibitor that Inhibits PD-L1 Expression and Lung Tumor Growth.

Rawangkan A, Wongsirisin P, Namiki K, Iida K, Kobayashi Y, Shimizu Y, Fujiki H, Suganuma M.

Molecules. 2018 Aug 18;23(8). pii: E2071. doi: 10.3390/molecules23082071.

2.

Cancer Prevention with Green Tea and Its Principal Constituent, EGCG: from Early Investigations to Current Focus on Human Cancer Stem Cells.

Fujiki H, Watanabe T, Sueoka E, Rawangkan A, Suganuma M.

Mol Cells. 2018 Feb 28;41(2):73-82. doi: 10.14348/molcells.2018.2227. Epub 2018 Jan 31. Review.

3.

Cell softening in malignant progression of human lung cancer cells by activation of receptor tyrosine kinase AXL.

Iida K, Sakai R, Yokoyama S, Kobayashi N, Togo S, Yoshikawa HY, Rawangkan A, Namiki K, Suganuma M.

Sci Rep. 2017 Dec 19;7(1):17770. doi: 10.1038/s41598-017-18120-4.

4.

Human cancer stem cells are a target for cancer prevention using (-)-epigallocatechin gallate.

Fujiki H, Sueoka E, Rawangkan A, Suganuma M.

J Cancer Res Clin Oncol. 2017 Dec;143(12):2401-2412. doi: 10.1007/s00432-017-2515-2. Epub 2017 Sep 23. Review.

5.

Phorbol esters in seed oil of Jatropha curcas L. (saboodam in Thai) and their association with cancer prevention: from the initial investigation to the present topics.

Fujiki H, Suttajit M, Rawangkan A, Iida K, Limtrakul P, Umsumarng S, Suganuma M.

J Cancer Res Clin Oncol. 2017 Aug;143(8):1359-1369. doi: 10.1007/s00432-017-2341-6. Epub 2017 Jan 25. Review.

6.

Down-regulation of histone deacetylase 4, -5 and -6 as a mechanism of synergistic enhancement of apoptosis in human lung cancer cells treated with the combination of a synthetic retinoid, Am80 and green tea catechin.

Oya Y, Mondal A, Rawangkan A, Umsumarng S, Iida K, Watanabe T, Kanno M, Suzuki K, Li Z, Kagechika H, Shudo K, Fujiki H, Suganuma M.

J Nutr Biochem. 2017 Apr;42:7-16. doi: 10.1016/j.jnutbio.2016.12.015. Epub 2017 Jan 8.

PMID:
28103535

Supplemental Content

Loading ...
Support Center